United States – Biopsy Testing Market & Volume Analysis to 2020
United States Biopsy Test Market was more than US$ 15 Billion in 2014 and future seems to be much brighter. In the United States Biopsy Test Market, Breast Cancer is the most popular segment in 2014. Thyroid cancer stands at the last spot, but it is the most rapidly increasing type of cancer in the United States. However if we make the analysis from the Volume point then Prostate Cancer is the most popular segment. Increasing United States prevalence of cancer, geriatric population and increasing demand for minimally invasive procedures are expected to drive market growth during the forecast period.
Renub Research report titled “United States – Biopsy Testing Market & Volume Analysis to 2020” provides a comprehensive assessment of the fast–evolving, high–growth of Biopsy Market. This 53 page report with 28 Figures and 1 Table analyses the United States Biopsy Test Market and Volume by 5 Top Cancer Segment, driving factors and challenges for Biopsy market.
The United States Biopsy Market has been analyzed from two view points
1. Breast Cancer
2. Prostate Cancer
3. Liver Cancer
4. Lung Cancer
5. Thyroid Cancer
Data Sources
This report is built using data and information sourced from proprietary databases, primary and secondary research and in–house analysis by Renub Research team of industry experts.
Primary sources include industry surveys and telephone interviews with industry experts.
Secondary sources information and data has been collected from various printable and non–printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.
Renub Research report titled “United States – Biopsy Testing Market & Volume Analysis to 2020” provides a comprehensive assessment of the fast–evolving, high–growth of Biopsy Market. This 53 page report with 28 Figures and 1 Table analyses the United States Biopsy Test Market and Volume by 5 Top Cancer Segment, driving factors and challenges for Biopsy market.
The United States Biopsy Market has been analyzed from two view points
- United States Biopy Test Market & Forecast (2008 – 2020)
- United States Biopy Test Volume & Forecast (2008 – 2020)
1. Breast Cancer
2. Prostate Cancer
3. Liver Cancer
4. Lung Cancer
5. Thyroid Cancer
Data Sources
This report is built using data and information sourced from proprietary databases, primary and secondary research and in–house analysis by Renub Research team of industry experts.
Primary sources include industry surveys and telephone interviews with industry experts.
Secondary sources information and data has been collected from various printable and non–printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.
1. EXECUTIVE SUMMARY
2. UNITED STATES BIOPSY TEST MARKET, VOLUME & FORECAST (2008 – 2020)
2.1 United States Biopsy Test Market & Forecast
2.2 United States Biopsy Test Volume & Forecast
3. UNITED STATES BIOPSY TEST MARKET & VOLUME SHARE ANALYSIS (2008 – 2020)
3.1 United States Biopsy Test Market Share & Forecast
3.2 United States Biopsy Test Volume Share & Forecast
4. UNITED STATES BIOPSY MARKET & VOLUME FORECAST – TEST SEGMENT ANALYSIS (2008 – 2020)
4.1 United States – Prostate Cancer Biopsy Test Market & Volume Forecast
4.1.1 United States – Prostate Cancer Biopsy Test Market & Forecast
4.1.2 United States – Prostate Cancer Biopsy Test Volume & Forecast
4.2 United States – Breast Cancer Biopsy Test Market & Volume Forecast
4.2.1 United States – Breast Cancer Biopsy Test Market & Forecast
4.2.2 United States – Breast Cancer Biopsy Test Volume & Forecast
4.3 United States – Lung Cancer Biopsy Test Market & Volume Forecast
4.3.1 United States – Lung Cancer Biopsy Test Market & Forecast
4.3.2 United States – Lung Cancer Biopsy Test Volume & Forecast
4.4 United States – Liver Cancer Biopsy Test Market & Volume Forecast
4.4.1 United States – Liver Cancer Biopsy Test Market & Forecast
4.4.2 United States – Liver Cancer Biopsy Test Volume & Forecast
4.5 United States – Thyroid Cancer Biopsy Test Market & Volume Forecast
4.5.1 United States – Thyroid Cancer Biopsy Test Market & Forecast
4.5.2 United States – Thyroid Cancer Biopsy Test Volume & Forecast
5. UNITED STATES BIOPSY TEST MARKET – GROWTH DRIVERS
5.1 Inadequate Screening Tests for Particular Cancers
5.2 Demand for Minimally–Invasive Biopsy Techniques
5.3 Advancement in Biopsy Techniques
5.3.1 Advances in Prostate Biopsy Techniques
5.3.2 Advances in Breast Biopsy Techniques
5.3.3 Advances in Lung Biopsy Techniques
5.3.4 Advances in Liver Biopsy Techniques
5.3.5 Advances in Thyroid Biopsy Techniques
6. UNITED STATES BIOPSY TEST MARKET – CHALLENGES
6.1 Breast Biopsy Reimbursement Bundling
6.2 Biopsy Limitations
2. UNITED STATES BIOPSY TEST MARKET, VOLUME & FORECAST (2008 – 2020)
2.1 United States Biopsy Test Market & Forecast
2.2 United States Biopsy Test Volume & Forecast
3. UNITED STATES BIOPSY TEST MARKET & VOLUME SHARE ANALYSIS (2008 – 2020)
3.1 United States Biopsy Test Market Share & Forecast
3.2 United States Biopsy Test Volume Share & Forecast
4. UNITED STATES BIOPSY MARKET & VOLUME FORECAST – TEST SEGMENT ANALYSIS (2008 – 2020)
4.1 United States – Prostate Cancer Biopsy Test Market & Volume Forecast
4.1.1 United States – Prostate Cancer Biopsy Test Market & Forecast
4.1.2 United States – Prostate Cancer Biopsy Test Volume & Forecast
4.2 United States – Breast Cancer Biopsy Test Market & Volume Forecast
4.2.1 United States – Breast Cancer Biopsy Test Market & Forecast
4.2.2 United States – Breast Cancer Biopsy Test Volume & Forecast
4.3 United States – Lung Cancer Biopsy Test Market & Volume Forecast
4.3.1 United States – Lung Cancer Biopsy Test Market & Forecast
4.3.2 United States – Lung Cancer Biopsy Test Volume & Forecast
4.4 United States – Liver Cancer Biopsy Test Market & Volume Forecast
4.4.1 United States – Liver Cancer Biopsy Test Market & Forecast
4.4.2 United States – Liver Cancer Biopsy Test Volume & Forecast
4.5 United States – Thyroid Cancer Biopsy Test Market & Volume Forecast
4.5.1 United States – Thyroid Cancer Biopsy Test Market & Forecast
4.5.2 United States – Thyroid Cancer Biopsy Test Volume & Forecast
5. UNITED STATES BIOPSY TEST MARKET – GROWTH DRIVERS
5.1 Inadequate Screening Tests for Particular Cancers
5.2 Demand for Minimally–Invasive Biopsy Techniques
5.3 Advancement in Biopsy Techniques
5.3.1 Advances in Prostate Biopsy Techniques
5.3.2 Advances in Breast Biopsy Techniques
5.3.3 Advances in Lung Biopsy Techniques
5.3.4 Advances in Liver Biopsy Techniques
5.3.5 Advances in Thyroid Biopsy Techniques
6. UNITED STATES BIOPSY TEST MARKET – CHALLENGES
6.1 Breast Biopsy Reimbursement Bundling
6.2 Biopsy Limitations
LIST OF FIGURES:
Figure 2–1: United States – Biopsy Test Market (Million US$), 2008 – 2014
Figure 2–2: United States – Forecast for Biopsy Test Market (Million US$), 2015 – 2020
Figure 2–3: United States – Biopsy Test Volume (Thousand), 2008 – 2014
Figure 2–4: United States – Forecast for Biopsy Test Volume (Thousand), 2015 – 2020
Figure 3–1: United States – Biopsy Test Market Share (Percent), 2008 – 2014
Figure 3–2: United States – Forecast for Biopsy Test Market Share (Percent), 2015 – 2020
Figure 3–3: United States – Biopsy Test Volume Share (Percent), 2008 – 2014
Figure 3–4: United States – Forecast for Biopsy Test Volume Share (Percent), 2015 – 2020
Figure 4–1: United States – Prostate Cancer Biopsy Test Market (Million US$), 2008 – 2014
Figure 4–2: United States – Forecast for Prostate Cancer Biopsy Test Market (Million US$), 2015 –2020
Figure 4–3: United States – Prostate Cancer Biopsy Test Volume (Thousand), 2008 – 2014
Figure 4–4: United States – Forecast for Prostate Cancer Biopsy Test Volume (Thousand), 2015 – 2020
Figure 4–5: United States – Breast Cancer Biopsy Test Market (Million US$), 2008 – 2014
Figure 4–6: United States – Forecast for Breast Cancer Biopsy Test Market (Million US$), 2015 – 2020
Figure 4–7: United States – Breast Cancer Biopsy Test Volume (Thousand), 2008 – 2014
Figure 4–8: United States – Forecast for Breast Cancer Biopsy Test Volume (Thousand), 2015 – 2020
Figure 4–9: United States – Lung Cancer Biopsy Test Market (Million US$), 2008 – 2014
Figure 4–10: United States – Forecast for Lung Cancer Biopsy Test Market (Million US$), 2015 – 2020
Figure 4–11: United States – Lung Cancer Biopsy Test Volume (Thousand), 2008 – 2014
Figure 4–12: United States – Forecast for Lung Cancer Biopsy Test Volume (Thousand), 2015 – 2020
Figure 4–13: United States – Liver Cancer Biopsy Test Market (Million US$), 2008 – 2014
Figure 4–14: United States – Forecast for Liver Cancer Biopsy Test Market (Million US$), 2015 – 2020
Figure 4–15: United States – Liver Cancer Biopsy Test Volume (Thousand), 2008 – 2014
Figure 4–16: United States – Forecast for Liver Cancer Biopsy Test Volume (Thousand), 2015 – 2020
Figure 4–17: United States – Thyroid Cancer Biopsy Test Market (Million US$), 2008 – 2014
Figure 4–18: United States – Forecast for Thyroid Cancer Biopsy Test Market (Million US$), 2015 –2020
Figure 4–19: United States – Thyroid Cancer Biopsy Test Volume (Thousand), 2008 – 2014
Figure 4–20: United States – Forecast for Thyroid Cancer Biopsy Test Volume (Thousand), 2015 –2020
Figure 2–1: United States – Biopsy Test Market (Million US$), 2008 – 2014
Figure 2–2: United States – Forecast for Biopsy Test Market (Million US$), 2015 – 2020
Figure 2–3: United States – Biopsy Test Volume (Thousand), 2008 – 2014
Figure 2–4: United States – Forecast for Biopsy Test Volume (Thousand), 2015 – 2020
Figure 3–1: United States – Biopsy Test Market Share (Percent), 2008 – 2014
Figure 3–2: United States – Forecast for Biopsy Test Market Share (Percent), 2015 – 2020
Figure 3–3: United States – Biopsy Test Volume Share (Percent), 2008 – 2014
Figure 3–4: United States – Forecast for Biopsy Test Volume Share (Percent), 2015 – 2020
Figure 4–1: United States – Prostate Cancer Biopsy Test Market (Million US$), 2008 – 2014
Figure 4–2: United States – Forecast for Prostate Cancer Biopsy Test Market (Million US$), 2015 –2020
Figure 4–3: United States – Prostate Cancer Biopsy Test Volume (Thousand), 2008 – 2014
Figure 4–4: United States – Forecast for Prostate Cancer Biopsy Test Volume (Thousand), 2015 – 2020
Figure 4–5: United States – Breast Cancer Biopsy Test Market (Million US$), 2008 – 2014
Figure 4–6: United States – Forecast for Breast Cancer Biopsy Test Market (Million US$), 2015 – 2020
Figure 4–7: United States – Breast Cancer Biopsy Test Volume (Thousand), 2008 – 2014
Figure 4–8: United States – Forecast for Breast Cancer Biopsy Test Volume (Thousand), 2015 – 2020
Figure 4–9: United States – Lung Cancer Biopsy Test Market (Million US$), 2008 – 2014
Figure 4–10: United States – Forecast for Lung Cancer Biopsy Test Market (Million US$), 2015 – 2020
Figure 4–11: United States – Lung Cancer Biopsy Test Volume (Thousand), 2008 – 2014
Figure 4–12: United States – Forecast for Lung Cancer Biopsy Test Volume (Thousand), 2015 – 2020
Figure 4–13: United States – Liver Cancer Biopsy Test Market (Million US$), 2008 – 2014
Figure 4–14: United States – Forecast for Liver Cancer Biopsy Test Market (Million US$), 2015 – 2020
Figure 4–15: United States – Liver Cancer Biopsy Test Volume (Thousand), 2008 – 2014
Figure 4–16: United States – Forecast for Liver Cancer Biopsy Test Volume (Thousand), 2015 – 2020
Figure 4–17: United States – Thyroid Cancer Biopsy Test Market (Million US$), 2008 – 2014
Figure 4–18: United States – Forecast for Thyroid Cancer Biopsy Test Market (Million US$), 2015 –2020
Figure 4–19: United States – Thyroid Cancer Biopsy Test Volume (Thousand), 2008 – 2014
Figure 4–20: United States – Forecast for Thyroid Cancer Biopsy Test Volume (Thousand), 2015 –2020
LIST OF TABLES:
Table 6–1: Breast Biopsy – Final Medicare Physician Fee Schedule, 2015
Table 6–1: Breast Biopsy – Final Medicare Physician Fee Schedule, 2015
